What is Adient's earnings per share (EPS)?

Adient (ADNT) reported diluted earnings per share of $-3.39 for fiscal year 2025. This represents a -1795.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Adient Financials

ADNT

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE September

This page shows Adient (ADNT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ADNT FY2025 2026-05-06

Adient runs on very thin gross margins, so working-capital discipline matters as much as the income statement.

From FY2023 to FY2025, inventory fell from $841M to $695M even as revenue softened, showing the balance sheet was being tightened rather than expanded to support sales. That matters because FY2025 still converted a net loss of -$281M into free cash flow of $204M, so recent cash resilience came more from working-capital release than from a wide margin cushion.

The balance sheet is more leveraged through shrinking equity than through new borrowing: long-term debt stayed near $2.4B, while debt-to-equity moved up as losses and buybacks reduced the equity base. A current ratio of 1.1x against total liabilities of $7.19B means liquidity is adequate but not roomy, so cash discipline matters more than a large buffer.

With gross margin at just 6.6%, this is a narrow-spread operating model where small cost changes can overwhelm the income statement; after SG&A and R&D, only about $52M of gross profit remained before depreciation and interest in FY2025. The helpful offset is moderate capital intensity: capex of $245M consumed only part of operating cash flow, allowing routine reinvestment without exhausting internally generated cash.

Financial Health Signals

Financial Profile 25/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Adient's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Adient's revenue declined 1% year-over-year, from $14.7B to $14.5B. This contraction results in a growth score of 29/100.

Leverage

Adient carries a low D/E ratio of 1.35, meaning only $1.35 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 74/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Adient's current ratio of 1.12 is below the typical benchmark, resulting in a score of 17/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Adient has a free cash flow margin of 1.4%, earning a moderate score of 30/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Adient generates a -15.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 0.8% the prior year.

Piotroski F-Score Neutral

6/9

Adient passes 6 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-1.60x

For every $1 of reported earnings, Adient generates $-1.60 in operating cash flow ($449.0M OCF vs -$281.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$14.5B

YoY-1.0%

5Y CAGR+2.8%

10Y CAGR-3.2%

Adient generated $14.5B in revenue in fiscal year 2025. This represents a decrease of 1.0% from the prior year.

EBITDA

N/A

Net Income

-$281.0M

YoY-1661.1%

Adient reported -$281.0M in net income in fiscal year 2025. This represents a decrease of 1661.1% from the prior year.

EPS (Diluted)

$-3.39

YoY-1795.0%

Adient earned $-3.39 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1795.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$204.0M

YoY-26.4%

Adient generated $204.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 26.4% from the prior year.

Cash & Debt

$958.0M

YoY+1.4%

5Y CAGR-10.8%

10Y CAGR+36.1%

Adient held $958.0M in cash against $2.4B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

79M

YoY-6.7%

5Y CAGR-3.4%

Adient had 79M shares outstanding in fiscal year 2025. This represents a decrease of 6.7% from the prior year.

Margins & Returns

Gross Margin

6.6%

YoY+0.3pp

5Y CAGR+1.9pp

10Y CAGR-2.6pp

Adient's gross margin was 6.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.

Operating Margin

N/A

Net Margin

-1.9%

YoY-2.1pp

5Y CAGR+2.4pp

10Y CAGR-4.2pp

Adient's net profit margin was -1.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2.1 percentage points from the prior year.

Return on Equity

-15.9%

YoY-16.8pp

5Y CAGR+29.2pp

10Y CAGR-23.9pp

Adient's ROE was -15.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 16.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$387.0M

YoY+4.0%

5Y CAGR+0.9%

10Y CAGR-4.3%

Adient invested $387.0M in research and development in fiscal year 2025. This represents an increase of 4.0% from the prior year.

Share Buybacks

$125.0M

YoY-54.5%

Adient spent $125.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 54.5% from the prior year.

Capital Expenditures

$245.0M

YoY-7.9%

5Y CAGR-5.6%

10Y CAGR-6.5%

Adient invested $245.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 7.9% from the prior year.

ADNT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$14.5B-1.0%	$14.7B-4.6%	$15.4B+9.0%	$14.1B+3.2%	$13.7B+8.0%	$12.7B
Cost of Revenue	$13.6B-1.4%	$13.8B-4.2%	$14.4B+7.9%	$13.3B+3.6%	$12.9B+6.4%	$12.1B
Gross Profit	$961.0M+3.6%	$928.0M-10.2%	$1.0B+28.0%	$807.0M-2.3%	$826.0M+39.5%	$592.0M
R&D Expenses	$387.0M+4.0%	$372.0M+2.8%	$362.0M+12.4%	$322.0M+1.9%	$316.0M-14.6%	$370.0M
SG&A Expenses	$522.0M+3.0%	$507.0M-8.5%	$554.0M-7.4%	$598.0M+11.4%	$537.0M-3.8%	$558.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$183.0M-2.1%	$187.0M+41.7%	$132.0M-31.3%	$192.0M-16.2%	$229.0M+12.8%	$203.0M
Income Tax	$103.0M+221.9%	$32.0M	$0-100.0%	$94.0M-62.2%	$249.0M+336.8%	$57.0M
Net Income	-$281.0M-1661.1%	$18.0M-91.2%	$205.0M+270.8%	-$120.0M-110.8%	$1.1B+302.6%	-$547.0M
EPS (Diluted)	$-3.39-1795.0%	$0.20-90.7%	$2.15+269.3%	$-1.27-111.0%	$11.58+298.6%	$-5.83

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$3.9B+6.1%	$3.6B-1.2%	$3.7B-1.4%	$3.7B+3.6%	$3.6B+3.3%	$3.5B-1.9%	$3.6B-4.1%	$3.7B
Cost of Revenue	$3.6B+5.3%	$3.4B-0.4%	$3.4B-1.8%	$3.5B+4.6%	$3.4B+2.2%	$3.3B-1.1%	$3.3B-5.5%	$3.5B
Gross Profit	$257.0M+18.4%	$217.0M-12.1%	$247.0M+4.2%	$237.0M-9.2%	$261.0M+20.8%	$216.0M-11.8%	$245.0M+18.4%	$207.0M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$138.0M+6.2%	$130.0M+4.8%	$124.0M-3.9%	$129.0M-10.4%	$144.0M+15.2%	$125.0M+0.8%	$124.0M+2.5%	$121.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	-$48.0M-190.6%	$53.0M-77.0%	$230.0M+551.0%	-$51.0M-6.3%	-$48.0M-192.3%	$52.0M-76.6%	$222.0M+562.5%	-$48.0M
Income Tax	$32.0M-23.8%	$42.0M+61.5%	$26.0M+271.4%	$7.0M-85.4%	$48.0M+118.2%	$22.0M+161.1%	-$36.0M-190.0%	$40.0M
Net Income	$27.0M+222.7%	-$22.0M-222.2%	$18.0M-50.0%	$36.0M+110.7%	-$335.0M	$0-100.0%	$79.0M+818.2%	-$11.0M
EPS (Diluted)	$0.34+221.4%	$-0.28	N/A	$0.43+110.8%	$-3.99	$0.00	N/A	$-0.12

ADNT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$9.0B-4.2%	$9.4B-0.8%	$9.4B+2.9%	$9.2B-15.0%	$10.8B+5.0%	$10.3B
Current Assets	$4.1B+1.2%	$4.1B-5.3%	$4.3B+3.7%	$4.2B-18.1%	$5.1B+13.5%	$4.5B
Cash & Equivalents	$958.0M+1.4%	$945.0M-14.9%	$1.1B+17.2%	$947.0M-37.7%	$1.5B-10.1%	$1.7B
Inventory	$695.0M-8.3%	$758.0M-9.9%	$841.0M-11.8%	$953.0M-2.4%	$976.0M+42.5%	$685.0M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.8B-16.5%	$2.2B+3.3%	$2.1B+1.8%	$2.1B-7.0%	$2.2B+7.5%	$2.1B
Total Liabilities	$7.2B-0.4%	$7.2B+0.3%	$7.2B+1.6%	$7.1B-15.7%	$8.4B-7.1%	$9.0B
Current Liabilities	$3.7B+0.2%	$3.7B-1.6%	$3.7B+6.8%	$3.5B-0.3%	$3.5B-8.1%	$3.8B
Long-Term Debt	$2.4B-0.4%	$2.4B-0.2%	$2.4B-6.4%	$2.6B-27.0%	$3.5B-14.3%	$4.1B
Total Equity	$1.8B-17.2%	$2.1B-4.2%	$2.2B+7.5%	$2.1B-12.8%	$2.4B+95.9%	$1.2B
Retained Earnings	-$1.2B-31.8%	-$885.0M+2.0%	-$903.0M+18.5%	-$1.1B-12.1%	-$988.0M+52.9%	-$2.1B

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$9.0B+2.9%	$8.8B-2.0%	$9.0B+1.3%	$8.8B+2.9%	$8.6B+0.7%	$8.5B-8.7%	$9.4B+2.8%	$9.1B
Current Assets	$4.2B+8.5%	$3.9B-5.3%	$4.1B+2.8%	$4.0B+3.3%	$3.9B+10.6%	$3.5B-13.9%	$4.1B+2.2%	$4.0B
Cash & Equivalents	$831.0M-2.8%	$855.0M-10.8%	$958.0M+11.4%	$860.0M+14.1%	$754.0M-12.3%	$860.0M-9.0%	$945.0M+6.2%	$890.0M
Inventory	$735.0M-3.3%	$760.0M+9.4%	$695.0M-4.3%	$726.0M+1.0%	$719.0M-0.3%	$721.0M-4.9%	$758.0M-2.2%	$775.0M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.8B-0.8%	$1.8B+0.3%	$1.8B+0.2%	$1.8B+1.1%	$1.8B-14.7%	$2.1B-3.4%	$2.2B+3.8%	$2.1B
Total Liabilities	$7.3B+4.0%	$7.0B-2.1%	$7.2B+1.9%	$7.1B+1.6%	$6.9B+4.2%	$6.7B-7.8%	$7.2B+0.7%	$7.2B
Current Liabilities	$3.9B+7.7%	$3.6B-2.6%	$3.7B+2.5%	$3.6B+2.5%	$3.5B+7.9%	$3.3B-11.6%	$3.7B-0.2%	$3.7B
Long-Term Debt	$2.4B0.0%	$2.4B-0.3%	$2.4B0.0%	$2.4B0.0%	$2.4B-0.3%	$2.4B-0.1%	$2.4B0.0%	$2.4B
Total Equity	$1.7B-1.3%	$1.7B-1.8%	$1.8B-1.1%	$1.8B+8.1%	$1.7B-12.0%	$1.9B-12.0%	$2.1B+10.7%	$1.9B
Retained Earnings	-$1.2B+2.3%	-$1.2B-1.9%	-$1.2B+1.5%	-$1.2B+3.0%	-$1.2B-37.9%	-$885.0M0.0%	-$885.0M+8.2%	-$964.0M

ADNT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$449.0M-17.3%	$543.0M-18.6%	$667.0M+143.4%	$274.0M+5.4%	$260.0M+5.7%	$246.0M
Capital Expenditures	$245.0M-7.9%	$266.0M+5.6%	$252.0M+11.0%	$227.0M-12.7%	$260.0M-20.2%	$326.0M
Free Cash Flow	$204.0M-26.4%	$277.0M-33.3%	$415.0M+783.0%	$47.0M	$0+100.0%	-$80.0M
Investing Cash Flow	-$186.0M+26.5%	-$253.0M-10.5%	-$229.0M-147.3%	$484.0M+39.5%	$347.0M+109.0%	$166.0M
Financing Cash Flow	-$267.0M+46.8%	-$502.0M-85.2%	-$271.0M+78.7%	-$1.3B-65.3%	-$770.0M-295.9%	$393.0M
Dividends Paid	N/A	N/A	N/A	N/A	$0	$0
Share Buybacks	$125.0M-54.5%	$275.0M+323.1%	$65.0M	$0	$0	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$81.0M+1.3%	$80.0M-62.4%	$213.0M+23.8%	$172.0M+482.2%	-$45.0M-141.3%	$109.0M-58.6%	$263.0M+66.5%	$158.0M
Capital Expenditures	$73.0M+12.3%	$65.0M-17.7%	$79.0M+38.6%	$57.0M+26.7%	$45.0M-29.7%	$64.0M-11.1%	$72.0M+2.9%	$70.0M
Free Cash Flow	$8.0M-46.7%	$15.0M-88.8%	$134.0M+16.5%	$115.0M+227.8%	-$90.0M-300.0%	$45.0M-76.4%	$191.0M+117.0%	$88.0M
Investing Cash Flow	-$75.0M-10.3%	-$68.0M-15.3%	-$59.0M-20.4%	-$49.0M-11.4%	-$44.0M-29.4%	-$34.0M+51.4%	-$70.0M0.0%	-$70.0M
Financing Cash Flow	-$7.0M+93.9%	-$114.0M-107.3%	-$55.0M+12.7%	-$63.0M-34.0%	-$47.0M+53.9%	-$102.0M+46.0%	-$189.0M-105.4%	-$92.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$25.0M-50.0%	$50.0M0.0%	$50.0M	$0-100.0%	$25.0M-50.0%	$50.0M-77.8%	$225.0M

ADNT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	6.6%+0.3pp	6.3%-0.4pp	6.7%+1.0pp	5.7%-0.3pp	6.0%+1.4pp	4.7%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-1.9%-2.1pp	0.1%-1.2pp	1.3%+2.2pp	-0.9%-8.9pp	8.1%+12.4pp	-4.3%
Return on Equity	-15.9%-16.8pp	0.8%-8.4pp	9.2%+15.0pp	-5.8%-52.4pp	46.6%+91.7pp	-45.1%
Return on Assets	-3.1%-3.3pp	0.2%-2.0pp	2.2%+3.5pp	-1.3%-11.6pp	10.3%+15.6pp	-5.3%
Current Ratio	1.12+0.0	1.11-0.0	1.15-0.0	1.19-0.3	1.45+0.3	1.17
Debt-to-Equity	1.35+0.2	1.12+0.0	1.08-0.2	1.24-0.2	1.48-1.9	3.38
FCF Margin	1.4%-0.5pp	1.9%-0.8pp	2.7%+2.4pp	0.3%+0.3pp	0.0%+0.6pp	-0.6%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	6.7%+0.7pp	5.9%-0.8pp	6.7%+0.4pp	6.3%-0.9pp	7.2%+1.1pp	6.2%-0.7pp	6.9%+1.3pp	5.6%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	0.7%+1.3pp	-0.6%-1.1pp	0.5%-0.5pp	1.0%+10.2pp	-9.3%-9.3pp	0.0%-2.2pp	2.2%+2.5pp	-0.3%
Return on Equity	1.6%+2.9pp	-1.3%-2.3pp	1.0%-1.0pp	2.0%+22.3pp	-20.3%-20.3pp	0.0%-3.7pp	3.7%+4.3pp	-0.6%
Return on Assets	0.3%+0.5pp	-0.3%-0.5pp	0.2%-0.2pp	0.4%+4.3pp	-3.9%-3.9pp	0.0%-0.8pp	0.8%+1.0pp	-0.1%
Current Ratio	1.100.0	1.09-0.0	1.120.0	1.120.0	1.11+0.0	1.08-0.0	1.11+0.0	1.08
Debt-to-Equity	1.39+0.0	1.37+0.0	1.35+0.0	1.34-0.1	1.44+0.2	1.28+0.2	1.12-0.1	1.24
FCF Margin	0.2%-0.2pp	0.4%-3.2pp	3.6%+0.6pp	3.1%+5.6pp	-2.5%-3.8pp	1.3%-4.1pp	5.4%+3.0pp	2.4%

Similar Companies

Goodyear Tire & Rubr Co GT

$1.7B

Phinia Inc PHIN

$3.0B

Dana Inc DAN

$3.7B

Garrett Motion GTX

$5.5B

Atmus Filtration Technologies Inc. ATMU

$4.6B

Frequently Asked Questions

What is Adient's annual revenue?

Adient (ADNT) reported $14.5B in total revenue for fiscal year 2025. This represents a -1.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Adient's revenue growing?

Adient (ADNT) revenue declined by 1% year-over-year, from $14.7B to $14.5B in fiscal year 2025.

Is Adient profitable?

No, Adient (ADNT) reported a net income of -$281.0M in fiscal year 2025, with a net profit margin of -1.9%.

How much debt does Adient have?

As of fiscal year 2025, Adient (ADNT) had $958.0M in cash and equivalents against $2.4B in long-term debt.

What is Adient's gross margin?

Adient (ADNT) had a gross margin of 6.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Adient's net profit margin?

Adient (ADNT) had a net profit margin of -1.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Adient's return on equity (ROE)?

Adient (ADNT) has a return on equity of -15.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Adient's free cash flow?

Adient (ADNT) generated $204.0M in free cash flow during fiscal year 2025. This represents a -26.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Adient's operating cash flow?

Adient (ADNT) generated $449.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Adient's total assets?

Adient (ADNT) had $9.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Adient's capital expenditures?

Adient (ADNT) invested $245.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Adient spend on research and development?

Adient (ADNT) invested $387.0M in research and development during fiscal year 2025.

Does Adient buy back shares?

Yes, Adient (ADNT) spent $125.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Adient have outstanding?

Adient (ADNT) had 79M shares outstanding as of fiscal year 2025.

What is Adient's current ratio?

Adient (ADNT) had a current ratio of 1.12 as of fiscal year 2025, which is considered adequate.

What is Adient's debt-to-equity ratio?

Adient (ADNT) had a debt-to-equity ratio of 1.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Adient's return on assets (ROA)?

Adient (ADNT) had a return on assets of -3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Adient's Piotroski F-Score?

Adient (ADNT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Adient's earnings high quality?

Adient (ADNT) has an earnings quality ratio of -1.60x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Adient?

Adient (ADNT) scores 25 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.